Bio-Rad Laboratories, Inc. 13D and 13G filings for OncoCyte Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-24 12:13 pm Purchase | 2024-10-04 | 13G | OncoCyte Corporation OCX | BIO-RAD LABORATORIES INC. BIO | 1,510,944 8.970% | 310,835 (+25.90%) | Filing |
| 2024-04-22 1:30 pm Purchase | 2024-04-15 | 13G | OncoCyte Corporation OCX | BIO-RAD LABORATORIES INC. BIO | 1,200,109 8.990% | 1,200,109 (New Position) | Filing |